Αποτελέσματα Αναζήτησης
16 Ιουλ 2021 · These guidelines bring in the most recent guidance on HIV testing strategies - the entry point for HIV prevention and treatment - and include comprehensive guidance on infant diagnosis. Key recommendations are presented on rapid antiretroviral therapy (ART) initiation and the use of dolutegravir.
- Global HIV Programme - World Health Organization (WHO)
Testing and diagnostics are critical components of the...
- HIV and AIDS - World Health Organization (WHO)
HIV is spread from the body fluids of an infected person,...
- WHO announces the update of the “Consolidated Guidelines on HIV ...
to consolidate the most recent guidance and recommendations...
- Updated recommendations on first-line and second-line antiretroviral ...
Overview. Update on recommendations on antiretroviral...
- Global HIV Programme - World Health Organization (WHO)
24 Ιουν 2021 · to consolidate the most recent guidance and recommendations related to HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations in order to give updated and accessible guidance to member states; to outline HIV, STI and viral hepatitis health intervention packages that are acceptable for different key ...
1 Ιαν 2018 · Overview. Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or emtricitabine, FTC) + efavirenz ...
12 Σεπ 2024 · Updates to the HIV and AIDS treatment recommendations developed by a panel of experts on the use of antiretroviral agents in adults and adolescents with HIV.
27 Ιουν 2024 · HIV/AIDS Treatment and Prevention Guidelines, prepared by expert panels, are available for download for health care providers and consumers. Learn more here.
6 Δεκ 2023 · HIV-2 Infection section of the guidelines has been updated with the following key information: • Because HIV-2 is intrinsically resistant to non-nucleoside reverse transcriptase inhibitors, the long-acting injectable regimen of cabotegravir (CAB) and rilpivirine is not recommended for
This guideline from the International Antiviral (formerly AIDS) Society–USA updates practice recommendations for managing HIV infection, including when to change antiviral regimens; use of preexposure prophylaxis to prevent infection in at-risk persons; care of pregnant persons with HIV, people aging with HIV, and people with substance use ...